GLP1R and type 2 diabetes mellitus: The study of Dawed and colleagues investigated whether genetic variants could predict response to GLP-1 receptor agonists in 4571 adults with type 2 diabetes across observational studies and RCTs, measuring HbA1c change after six months [49].